Globeflex Capital L P purchased a new stake in shares of inTEST Co. (NYSE:INTT - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 122,730 shares of the company's stock, valued at approximately $2,230,000. Globeflex Capital L P owned about 0.98% of inTEST as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in INTT. BlackRock Inc. purchased a new position in inTEST in the 2nd quarter worth approximately $17,008,000. Bard Associates Inc. purchased a new stake in inTEST during the 2nd quarter valued at $3,827,000. Royce & Associates LP boosted its stake in inTEST by 7.3% during the 4th quarter. Royce & Associates LP now owns 1,555,020 shares of the company's stock valued at $11,616,000 after purchasing an additional 106,222 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new stake in shares of inTEST in the 1st quarter worth $1,275,000. Finally, Sei Investments Co. bought a new stake in shares of inTEST in the 1st quarter worth $1,185,000. Institutional investors own 63.18% of the company's stock.
inTEST Price Performance
Shares of INTT stock opened at $11.68 on Monday. The company has a current ratio of 2.26, a quick ratio of 1.38 and a debt-to-equity ratio of 0.08. inTEST Co. has a 12 month low of $6.85 and a 12 month high of $20.00. The stock has a market cap of $149.81 million, a P/E ratio of 50.78 and a beta of 1.51. The company has a 50 day simple moving average of $14.89 and a two-hundred day simple moving average of $14.74.
Analyst Ratings Changes
INTT has been the topic of a number of research analyst reports. Northland Securities raised inTEST from a "market perform" rating to an "outperform" rating and set a $15.00 price target on the stock in a report on Monday, August 3rd. Zacks Research downgraded inTEST from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $17.00.
Read Our Latest Research Report on inTEST
inTEST Profile
(
Free Report)
inTEST Corporation NYSE: INTT is a developer and manufacturer of precision instrumentation and test solutions designed for the semiconductor, microelectronics and related manufacturing industries. The company's offerings focus on thermal management and instrument interface technologies that support the environmental conditioning and electrical performance evaluation of devices under test. These solutions include temperature controllers and cyclers, thermal subsystems, load boards, connectors and custom test interfaces engineered to accelerate reliability testing, product qualification and high-volume production measurement.
Serving customers across North America, Europe and Asia, inTEST supports semiconductor fabs, assembly and packaging facilities, research laboratories and OEM equipment builders.
Further Reading
Want to see what other hedge funds are holding INTT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for inTEST Co. (NYSE:INTT - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider inTEST, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and inTEST wasn't on the list.
While inTEST currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
